Company invites individual and institutional investors as well as advisors to attend real-time, VirtualInvestorConferences.com
SAN DIEGO, Feb. 27, 2015 /PRNewswire/ — Organovo Holdings, Inc. (NYSE MKT: ONVO) („Organovo“), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Keith Murphy, President and Chief Executive Officer, will present live at VirtualInvestorConferences.com on March 5th.
„We invite you to join us for this Company update,“ said Mr. Murphy. „We plan to provide updates on our commercial launch of the exVive3D Liver, Bioprinted Human Tissue, commercialization milestones for 3D bioprinted kidney tissue, and additional exciting opportunities for the Company’s future growth.“
For investors who are not yet familiar with the Company and desire background information, including an understanding of the 3D bioprinting technology used by Organovo to create functional living human tissues, investors can watch an informational background presentation on the Company’s website:
(…weiter auf organovo.com)